Is complement good or bad for cancer patients? A new perspective on an old dilemma

This publication has 76 references indexed in Scilit:

• The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
  The American Journal of Pathology, 2007
• Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
  Molecular Immunology, 2007
• Molecular viral oncology of hepatocellular carcinoma
  Oncogene, 2003
• Epstein–Barr virus and oncogenesis: from latent genes to tumours
  Oncogene, 2003
• Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1
  Blood, 2003
• In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas
  Blood, 2003
• Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid
  Clinical and Experimental Immunology, 2003
• Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
  New England Journal of Medicine, 2003
• Inflammation and cancer
  Nature, 2002
• Rules for Making Human Tumor Cells
  New England Journal of Medicine, 2002